OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
38
Results
Show all
Save search
Copy query
Show results for
Unknown
(38)
Publication Date
Release Date
2022
(6)
2016
(6)
2020
(4)
2019
(4)
2023
(3)
2017
(3)
2026
(2)
2025
(2)
2024
(2)
2021
(2)
2018
(1)
2015
(1)
2012
(1)
2010
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.
Not available
S-EPMC5559888
|
biostudies-literature
Cite
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.
Not available
S-EPMC6804912
|
biostudies-literature
Cite
ΔFosB Regulates Gene Expression and Cognitive Dysfunction in a Mouse Model of Alzheimer's Disease.
Not available
S-EPMC5785235
|
biostudies-literature
Cite
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.
Not available
S-EPMC9899839
|
biostudies-literature
Cite
Development and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial.
Not available
S-EPMC8056554
|
biostudies-literature
Cite
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe).
Not available
S-EPMC5599085
|
biostudies-literature
Cite
Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA).
Not available
S-EPMC9037491
|
biostudies-literature
Cite
Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma.
Not available
S-EPMC12853468
|
biostudies-literature
Cite
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study.
Not available
S-EPMC9748991
|
biostudies-literature
Cite
Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature.
Not available
S-EPMC7413872
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets